To study phase 1 study which compare Docecal and Taxotere in metastatic breast cancer.

Next Previous
Trial Profile

To study phase 1 study which compare Docecal and Taxotere in metastatic breast cancer.

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 02 Mar 2018

At a glance

  • Drugs Docetaxel (Primary)
  • Indications Breast cancer
  • Focus Adverse reactions

    • Most Recent Events

    • 02 Mar 2018 According to an Oasmia Pharmaceutical media release, data from the study will support the sales and marketing submission in Russia, as well as the registration discussions in other countries.
    • 22 Feb 2018 According to an Oasmia Pharmaceutical media release, 228 patients had been enrolled in two studied of Docecal in comparison with Taxotere (CTP 293315 and CTP 293313 ) from 17 clinical sites in five countries.
    • 22 Feb 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top